期刊文献+

禽流感病毒H5N1抗原基因克隆及体外转录 被引量:3

Cloning of HA,NA and M gene of H5N1 avian influenza virus and preparation of RNA fragments with transcription in vitro
原文传递
导出
摘要 目的通过基因克隆和体外转录,获得H5N1禽流感病毒抗原基因的RNA全长片段,为病原学检测提供阳性定量标准品。方法设计H5N1禽流感病毒血凝素(HA)、神经氨酸酶(NA)及基质蛋白M(M)的基因克隆引物,RT-PCR从病毒RNA获得相应片段,分别连接至pGEM-T Easy质粒并筛选阳性重组质粒,测序鉴定后酶切线性化,用T7 RNA聚合酶进行体外转录,产物用DNase酶处理、纯化后测定浓度,RT-PCR验证。结果获得含H5N1禽流感病毒HA、NA、M全长基因序列的RNA片段,并可准确定量其拷贝数,质量浓度HA为503.9 ng/μL、NA为379.2 ng/μL、M为437.8 ng/μL。结论获得的RNA片段可作为H5N1禽流感病毒核酸快速检测方法的阳性定量标准品。 Objective To transcript RNA in vitro in order to obtain quantitative standard for detecting mRNA of H5N1 avian influenza virus.Methods According to the specific sequence of HA/NA/M gene of H5N1 avian influenza virus,the primers were designed and synthesized.The fragments generated by RT-PCR were cloned into the pGEM-T Easy vector with T7 cloning protocol.The positive recombinant linearized plasmids were used to transcript RNA in vitro and the RNA was used as standard quantitative template of RT-PCR method.Results Specific framents were amplified from virus culture medium,which were confirmed by DNA cloning and sequencing.The full-length cRNA of HA/NA/M gene of H5N1 avian influenza virus with precise quantification copy number was obtained successfully.Conclusion The HA/NA/M cRNA obtained could be used as quantitative standard for rapid detection of nucleic acid of H5N1 avian influenza virus.
出处 《中国公共卫生》 CAS CSCD 北大核心 2010年第4期385-387,共3页 Chinese Journal of Public Health
基金 江苏省科技支撑计划(社会发展)项目(BE2009621) 南京军区重点课题(07Z043) 南京军区面上课题(08MB149)
关键词 禽流感病毒 H5N1亚型 克隆 体外转录 avian influenza virus H5N1 subtype cloning transcription in vitro
  • 相关文献

参考文献10

  • 1王天宇,赵景波.我国禽流感预防控制战略管理与实施[J].中国公共卫生,2007,23(6):765-766. 被引量:9
  • 2Uyeki TM. Global epidemiology of human infections with highly pathogenic avian influenza A ( H5N1 ) viruses [ J ]. Respirology,2008,43( 1 ) :2 -9.
  • 3Mackay WG, van Loon AM, Niedrig M, et al. Molecular detection and typing of influenza viruses: Are we ready for an influenza pandemic? [J]. J Clin Virol, 2008,42(2) :194- 197.
  • 4美国国家生物信息中心基因库(NCBI Gen Bank)[EB].登录号:DQ997538.
  • 5美国国家生物信息中心基因库(NCBI Gen Bank)[EB].登录号:EU263355.
  • 6美国国家生物信息中心基因库(NCBI Gen Bank)[EB].登录号:DQ997537.
  • 7甄世祺,王民生,鲍昌俊,袁家牛,张寄宁.人感染致病性禽流感应急演练存在问题与对策[J].中国公共卫生,2007,23(11):1386-1387. 被引量:8
  • 8Wunderli W. From diagnosis to the detection of avian influenza virus [ J]. Ther Umsch ,2007,64 ( 11 ) :609 - 612.
  • 9Gyarmati P,Conze T,Zohari S,et al. Simultaneous genotyping of all hemagglutinin and neuraminidase subtypes of avian influenza viruses by use of padlock probes [ J ]. J Clin Microbiol, 2008,46 (5) :1747 - 1751.
  • 10Imai M,Ninomiya A,Minekawa H,et al. Rapid diagnosis of H5N1 avian influenza virus infection by newly developed influenza H5 hemagglutinin gene-specific loop-mediated isothermal amplification method[ J]. J Virol Methods,2007,141 (2) : 173 - 180.

二级参考文献11

共引文献14

同被引文献33

  • 1黄平,柯昌文,邹丽容,李晖,陈秋霞.广东地区人禽流感H_5N_1血凝素基因特征与进化[J].中国公共卫生,2007,23(4):390-392. 被引量:11
  • 2王文邦,吴峰,孙华明,彭青宇,欧渝.未雨绸缪 严防严控 切实做好非疫区部队禽流感防控工作[J].解放军预防医学杂志,2007,25(2):127-128. 被引量:2
  • 3何良元,董剩勇,马耀兵.某部加强高致病性禽流感防控工作的做法[J].解放军预防医学杂志,2007,25(2):131-132. 被引量:3
  • 4J.莎姆布鲁克(著),黄培堂(译).分子克隆实验指南[M].3版.北京:科学出版社,2002:1428-1480.
  • 5Sym D,Patel PN,EI-Chaar GM. Seasonal,avian,and novel H1N1 influenza: prevention and treatment modalities [ J ]. Ann Pharmacotlaer,2009,43 (12) :2001 - 2011.
  • 6Mitrasinovic PM. Advances in the structure-based design of the influenza A neuraminidase inhibitors[J]. Curr Drug Targets. 2010, 11 (3) :315 -326.
  • 7Li Z, Xiong F, Lin Q, et al. Low-temperature increases the yield of biologically active herring antifreeze protein in Pichia pastoris [J]. Protein Expr Purif,2001,21 (3) :438 -445.
  • 8Cregg JM ,Cereghino JL, Shi J, et al. Recombinant protein expression in Pichia pastoris[J]. Mol Biotechnol,2000,16 ( 1 ) :23 - 52.
  • 9Keitel WA,Atmax RL.Preparing for a possible pandemic: influenza A/H5N1 vaccine development [ J ]. Curr Opin Pharmanol, 2007,7(5) :484 -490.
  • 10Stiver HG. The threat and prospects for control of an influenza pandemic[ J]. Expert Rev Vaccines,2004,3 ( 1 ) :35 -42.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部